Valuation: MediPharm Labs Corp.

Capitalization 2.7Cr 1.97Cr 1.69Cr 1.57Cr 1.45Cr 169.07Cr 3Cr 19Cr 7.18Cr 79Cr 7.39Cr 7.24Cr 288.74Cr P/E ratio 2025 *
-
P/E ratio 2026 * -
Enterprise value 2.7Cr 1.97Cr 1.69Cr 1.57Cr 1.45Cr 169.07Cr 3Cr 19Cr 7.18Cr 79Cr 7.39Cr 7.24Cr 288.74Cr EV / Sales 2025 *
0.58x
EV / Sales 2026 * 0.5x
Free-Float
94.64%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 week-7.14%
Current month-7.14%
1 month-18.75%
3 months-23.53%
6 months-13.33%
Current year+8.33%
More quotes
1 week 0.06
Extreme 0.065
0.07
1 month 0.06
Extreme 0.065
0.08
Current year 0.06
Extreme 0.06
0.12
1 year 0.06
Extreme 0.06
0.12
3 years 0.06
Extreme 0.055
0.12
5 years 0.06
Extreme 0.055
1.25
10 years 0.06
Extreme 0.055
7.39
More quotes
Manager TitleAgeSince
Chief Executive Officer - 20/04/2022
Director of Finance/CFO - 08/02/2021
Chief Tech/Sci/R&D Officer - 01/11/2016
Director TitleAgeSince
Chairman - 17/08/2021
Director/Board Member - 04/08/2020
Director/Board Member - 20/04/2022
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
0.00%-7.14%-7.14%+8.33% 1.97Cr
+3.89%+22.33%-48.51%-58.16% 86Cr
+22.22%+44.74%-67.96%-74.65% 75Cr
+15.00%+15.00%+27.78%-56.05% 42Cr
Average +10.28%+5.70%-23.96%-45.13% 51.1Cr
Weighted average by Cap. +12.81%+11.85%-39.64%-63.11%
See all sector performances

Financials

2025 *2026 *
Net sales 4.63Cr 3.38Cr 2.89Cr 2.7Cr 2.49Cr 289.94Cr 5.15Cr 32Cr 12Cr 135.47Cr 13Cr 12Cr 495.16Cr 5.36Cr 3.91Cr 3.35Cr 3.12Cr 2.89Cr 335.68Cr 5.96Cr 37Cr 14Cr 156.85Cr 15Cr 14Cr 573.27Cr
Net income -14.66L -10.71L -9L -9L -8L -9.18Cr -16.32L -1.02Cr -38.99L -4.29Cr -40.16L -39.34L -16Cr 6L 5L 4L 4L 3L 4.05Cr 7L 45.01L 17.19L 1.89Cr 17.71L 17.34L 6.91Cr
Net Debt - -
More financial data * Estimated data
Logo MediPharm Labs Corp.
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
Employees
161
More about the company
Date Price Change Volume
10/25/10 0.0650 $ 0.00% 58,653
09/25/09 0.0650 $ 0.00% 1,45,211
08/25/08 0.0650 $ 0.00% 25,436
07/25/07 0.0650 $ 0.00% 1,03,268
04/25/04 0.0650 $ 0.00% 1,20,312

Delayed Quote Toronto S.E., July 11, 2025 at 01:29 am IST

More quotes
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0650
Average target price
-
Consensus

Quarterly revenue - Rate of surprise